These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18097160)

  • 1. Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease?
    Gitler AD
    Neurosignals; 2008; 16(1):52-62. PubMed ID: 18097160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
    Outeiro TF; Giorgini F
    Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast unfolds the road map toward alpha-synuclein-induced cell death.
    Franssens V; Boelen E; Anandhakumar J; Vanhelmont T; Büttner S; Winderickx J
    Cell Death Differ; 2010 May; 17(5):746-53. PubMed ID: 20019751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurodegenerative conformational disease and its molecular bases].
    Li WW; Cai DF; Ren HM
    Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple is good: yeast models of neurodegeneration.
    Tenreiro S; Outeiro TF
    FEMS Yeast Res; 2010 Dec; 10(8):970-9. PubMed ID: 20579105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw.
    Spires TL; Hannan AJ
    FEBS J; 2005 May; 272(10):2347-61. PubMed ID: 15885086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders.
    Ocampo A; Barrientos A
    Biotechniques; 2008 Oct; 45(4):vii-xiv. PubMed ID: 18855765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
    Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What transgenic mice tell us about neurodegenerative disease.
    Gurney ME
    Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes and the environment in neurodegeneration.
    Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
    Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring polyglutamine toxicity in yeast.
    Duennwald ML
    Methods; 2011 Mar; 53(3):232-7. PubMed ID: 21144902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of disease II: cellular protein quality control.
    Outeiro TF; Tetzlaff J
    Semin Pediatr Neurol; 2007 Mar; 14(1):15-25. PubMed ID: 17331880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?
    Thompson A; Boekhoorn K; Van Dam AM; Lucassen PJ
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():28-42. PubMed ID: 18184368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Genomics meets neurodegenerative disorders. Part II: application and data integration.
    Hoerndli F; David DC; Götz J
    Prog Neurobiol; 2005 Jun; 76(3):169-88. PubMed ID: 16169146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.